Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) discusses the 2-year data from the MIMICS-3D Registry.
The aim of the registry is to investigate the safety, effectiveness and device performance of the BioMimics 3D Stent System in patients undergoing endovascular intervention, to relieve symptomatic peripheral arterial disease of the femoropopliteal artery.
Recorded remotely from Arnsberg, 2021.
Questions
1. What is the importance of the BioMimics 3D Real-World Registry?
2. Can you explain the objectives and rationale of the MIMICS-3D Registry?
3. What does the 2-year data tell us?
4. In which indications should physicians use this sent?
5. What are the take-home messages for physicians?
Editor: Mirjam Boros
Recording Editor: Natascha Wienand